Sigyn Therapeutics issues 118,700 shares on conversion of $474,793 in debentures at $4.00/share

Sigyn Therapeutics, Inc.

Holders of $474,793 in convertible debentures converted at $4.00/share; 118,700 restricted shares issued.
Outstanding common shares increased from 1,301,978 to 1,420,678 as a result.
Conversion exempt from registration under Section 4(a)(2); holders are executive-officer-controlled accredited investors.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.